ArticleCell death & disease2025

Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients.

Luisa Amato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.